Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Rebecca Panks

  • Home
  • Author: Rebecca Panks

Space infrastructure boom expected by 2030 as countries battle for geopolitical dominance and companies seek first-mover advantage, says GlobalData

Despite some teething problems at NASA, there will be a boom in space infrastructure such as space stations by 2030, according to GlobalData, a leading data and analytics company. Artemis I fuel leak may undermine confidence but market on track by 2030 While the trials and tribulations of NASA’s Artemis I moon mission will undermine […]
Read more

Healthcare providers need to step up investment in medical robots to cope with growing demand for hospital beds and workforce, says GlobalData

The share of people aged over 65 years in the global population is expected to increase from 9.6% in 2020 to 11.8% in 2030, according to GlobalData, placing additional strain on already stretched healthcare infrastructure. The leading data and analytics company notes that healthcare providers will need to increase investment in medical robots such as […]
Read more

Banking will be centered around the smartphone by 2030 as all countries become functionally cashless, says GlobalData

All countries will be functionally cashless by 2030, according to GlobalData. The leading data and analytics company notes that even developing nations in Asia and Africa are jumping straight from physical cash to mobile payments. $140 trillion worth of transactions made by mobile wallets by 2030 This prediction came about as part of GlobalData’s latest […]
Read more

Sanofi and Regeneron’s positive data for Dupixent in children will help companies remain market leaders for next five to 10 years, says GlobalData

Following the news that Sanofi and Regeneron presented analyses from the LIBERTY AD PRESCHOOL (NCT03346434) study of interleukin (IL)-4/13 inhibitor, Dupixent (dupilumab), at the European Academy of Dermatology and Venereology (EADV) 2022; Ramla Salad, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “Dupixent is proving to be very efficacious, even […]
Read more

Breakfast menus will boost struggling restaurants, as 44% of Americans report high spending in coffee and tea shops, says GlobalData

Restaurants in the US that are struggling to stay afloat should consider selling breakfasts, according to GlobalData, which notes that the breakfast category is the only one not seeing decline. The leading data and analytics company found that 43% of Americans now report eating out less frequently*, but could be tempted to grab a breakfast if it was convenient and affordable. Breakfast sales benefit from 44% of US customers returning to office work According to a consumer survey by GlobalData, 44%* of US […]
Read more

Remote patient monitoring devices set to become $760 million industry by 2030 they help keep elderly patients at home reducing burden on hospitals, says GlobalData

The use of efficient remote patient monitoring (RPM*) technology will be vital to prevent healthcare systems from becoming overburdened as the global population ages, according to GlobalData, a leading data and analytics company. Remote patient monitoring devices market to be worth $760 million by 2030 The RPM devices market was one of the fastest-growing industries […]
Read more

Power companies on track for energy transition but must not neglect full ESG responsibilities, says GlobalData

Power companies will face increasing pressure to respond to both social and governance issues while navigating their way through the energy transition process in the following decade, according to GlobalData, a leading data and analytics company. A focus on ‘E’ in ‘ESG’: 40% global power to come from renewables by 2030 GlobalData’s latest report, ‘ESG […]
Read more

Online shopping trend to completely change how we shop at physical stores by 2030, predicts GlobalData

People love the convenience of shopping online, and experts at GlobalData believe that, by 2030, this will have an even greater impact on the high street than we see today. The leading data and analytics company predicts that stores will focus on ‘customer experiences’, which includes increased personalization of products; malls becoming ‘entertainment centers’ alongside […]
Read more

Malfunctions in heart surgery device MitraClip could cost 600 patients millions in follow-up surgery and may end Abbott’s market supremacy, says GlobalData

With transcatheter mitral valve repair (TMVR) heart surgery being one of the fastest-growing fields in the realm of heart surgery at the moment—leading data and analytics company GlobalData expects the market to more than double in size to $3.4bn by 2030—it would appear to be plain sailing for Abbott as its TMVR therapy MitraClip is […]
Read more

Mobile gaming to represent over 50% of revenues in what will be a $470 billion gaming industry by 2030, says GlobalData

Mobile gaming is where the money is, according to GlobalData, which notes that these games will represent over half of gaming industry revenues in 2030. The leading data and analytics company presents a striking chart from its Video Games Research report showing the continued dominance of mobile gaming—which includes games played on both smartphones and […]
Read more

Global telecoms service providers are being ‘net-zero heroes’, but we must be mindful of greenwashing risks when it comes to far-off targets, says GlobalData

The recent substantial damage that floods have caused in Pakistan is a devastating reminder that climate change remains the single most important challenge facing the planet. Research by GlobalData has revealed that the technology and telecoms sector are being ‘net-zero heroes’ by making ‘sustainability’ an operational priority. The leading data and analytics company notes that […]
Read more

Neither Convidecia Air nor BBV154 are first inhaled COVID-19 vaccines to be approved, but this category could be key to breaking COVID-19 wave cycle, says GlobalData

Contrary to some media claims, neither CanSino Biologics’ Convidecia Air nor Bharat Biotech’s BBV154 are the first inhaled COVID-19 vaccines to market, according to GlobalData, which highlights that two such vaccines were approved in Russia in March and July this year. However, the leading data and analytics company notes that the trend towards inhaled vaccines […]
Read more
1 … 4 5 6 7 8 … 77